To ensure that 1DegreeBio upholds the highest scientific standards, the management team has brought together a group of scientific advisors to collaborate closely with 1DegreeBio in the ongoing development of the site. Dr. Lori Frappier, Dr. Aled Edwards, Dr. Brian Marsden and Dr. Sachdev Sidhu have signed on as 1DegreeBio's team of Scientific Advisors.
Dr. Lori Frappier
Dr. Frappier is a Professor in the Department of Molecular Genetics at the University of Toronto and a Canada Research Chair in Molecular Virology, and trained at McGill and Cornell universities. Dr. Frappier's team studies the proteins and mechanism associated with Epstein-Barr virus (EBV), a virus that is associated with a growing list of cancers.
Dr. Aled Edwards
Dr. Edwards is the Director and CEO of the SGC, a $125M international public-private partnership that focuses on the structural and chemical biology of human proteins relevant to drug discovery. Trained at McGill and Stanford, Dr. Edwards co-founded Affinium Pharmaceuticals and helped launch SiRem, a bioremediation company in Guelph. He served on the Scientific Advisory Boards of the Alberta Heritage Foundation for Medical Research, NorComm, the North American Conditional Mouse Mutagenesis project, and the Midwest Center for Structural Genomics at Argonne National Labs in Chicago. Dr. Edwards is the Banbury Chair of Medical Research at the University of Toronto and Visiting Professor of Chemical Biology at the University of Oxford.
Dr. Sachdev Sidhu
Dr. Sidhu is currently an Associate Investigator at the Ontario Institute for Cancer Research and is a member of the InVitro Affinity Reagent Consortium. Prior to coming to Toronto, Dr. Sidhu led the Antibody Engineering team at Genentech. His research interests focus on the use of combinatorial biology methods to explore protein structure and function, and his group is currently using combinatorial libraries to develop synthetic peptides, proteins and antibodies that can be used to track and modulate signaling proteins. He has published more than 50 scientific papers and is a co-inventor on 12 patents filed with the US patent office.
Dr. Brian Marsden
Dr. Marsden leads the Research Informatics group within the SGC in Oxford. His group provides bioinformatics, cheminformatics, computational chemistry and modelling support. Dr. Marsden obtained his Doctorate in Philosophy from the University of Oxford in 2000 and worked previously in the drug discovery sector.
Dr. Daniel Durocher
Dr Durocher is a senior investigator at the Centre for Systems Biology at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto. Dr Durocher obtained his PhD in 1998 from McGill University and joined the Samuel Lunenfeld Research Institute in 2001 as an investigator with the Centre for Systems Biology. In 2007, he was promoted to associate professor at the Department of Molecular Genetics at the University of Toronto. Dr Durocher is the Thomas Kierans Research Chair in Mechanisms of Cancer Development. Dr Durocher has won numerous awards, including a "Canada's Top 40 Under 40" award in 2010.